...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>The Laryngoscope: A Medical Journal for Clinical and Research Contributions in Otolaryngology, Head and Neck Medicine and Surgery, Facial Plastic and Reconstructive Surgery .. >Treatment of ranula in pediatric patients with intralesional injection of OK-432.
【24h】

Treatment of ranula in pediatric patients with intralesional injection of OK-432.

机译：病灶内注射OK-432治疗小儿排脓。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

OBJECTIVE: To assess the efficacy of treatment of a ranula in children by intralesional injection of OK-432. STUDY DESIGN: Retrospective analysis of 13 cases. METHODS: Review of medical records of pediatric patients with ranula treated by OK-432 sclerotherapy from 2002 through 2005. RESULTS: Among 13 cases, 9 were completely regressed by injection therapy alone. Three cases were incompletely regressed. One case was cured by surgical excision. The follow-up duration was 6 to 46 (mean 24.3) months. Adverse effects of OK-432 injection were tolerable, and no complication was observed. CONCLUSIONS: On the basis of our experience, sclerotherapy with OK-432 was a safe and effective primary treatment for a ranula in children. Further study will be needed to conclude its long-term effectiveness.
机译：目的：通过病灶内注射OK-432评估儿童排脓的疗效。研究设计：回顾性分析13例。方法：回顾性分析2002年至2005年行OK-432硬化疗法治疗小儿排脓的病历。结果：在13例患者中，有9例仅通过注射疗法完全消退。 3例未完全退回。 1例经手术切除治愈。随访时间为6到46（平均24.3）个月。 OK-432注射液的不良反应是可以忍受的，并且没有观察到并发症。结论：根据我们的经验，使用OK-432进行硬化疗法是治疗儿童泪膜的一种安全有效的主要方法。需要进一步研究以得出其长期有效性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号